JGH Medical Grand Rounds for the month of June
The Medical Grand Rounds take place on Mondays from 12:55 to 2:00 p.m. via Zoom.
For the Zoom details, click .
**
June 1, 2020
COMMUNITY-ACQUIRED PNEUMONIA: SO COMMON BUT SO COMPLICATED IN 2020?
Karl Weiss, MD, MSc, FRCPC
Professor of Medicine, Department of Medicine, Ï㽶ÊÓƵ
Chief, Division of Infectious Diseases, Jewish General Hospital
President of the Association of Infectious Diseases and Microbiology Physicians of Quebec
Educational Objectives:
1. Discuss the value and indication of laboratory tests and imaging for the diagnosis of CAP
2. Discuss the empirical antibiotic regimens in the treatment of CAP in different settings
3. Discuss the value of immunization in the prevention of community-acquired pneumonia
Contact Person: Karl Weiss, MD, Chief, Division of Infectious Diseases, Tel. 514-340-8222 ext. 28294.
**
June 8, 2020
ZOOM COMBINED JGH-MUHC MEDICAL GRAND ROUNDS
SPECIAL PRESENTATION IN MEMORY OF DR. SUSAN SOLYMOSS
COVID-19 ASSOCIATED COAGULOPATHY AND THROMBOSIS AND THE CLINICAL IMPLICATIONS
Véronique Naessens, MD
Assistant Professor, Department of Medicine, Ï㽶ÊÓƵ
Division of Hematology, MUHC
Vicky Tagalakis, MD MSc
Associate Professor of Medicine
Director, Division of General Internal Medicine
Division of Internal Medicine, and Centre for Clinical Epidemiology of the Lady Davis Institute for Medical Research
Susan Kahn, MD. MSc
Canada Research Chair
Professor of Medicine, Ï㽶ÊÓƵ
Director, JGH Centre of Excellence in Thrombosis and Anticoagulation Care (CETAC)
Educational Objectives:
1. To understand the coagulation changes observed in patients with COVID-19 and associated implications
2. To learn of unique COVID-19 changes in lung vasculature
3. To understand the importance of thromboprophylaxis in COVID-19 patients and when to intensify anticoagulation
Contact Person: Vicky Tagalakis, MD, MSc, Division of Internal Medicine, Tel. 514-340-7596.
**
June 15, 2020
A RETROSPECTIVE END OF LIFE STUDY OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES AND THE IMPORTANCE OF END OF LIFE DISCUSSION IN SERIOUS ILLNESS
Victoria Korsos
PGY-5 Hematology Resident
Ï㽶ÊÓƵ
&
Chantal Cassis MD, MEd, FRCPC
McGill Hematology Program Director
Assistant Professor, Department of Medicine, Ï㽶ÊÓƵ
Staff Member, Division of Hematology, Jewish General Hospital
Educational Objectives:
1. Describe the demographics and trajectory of hematology patients at the end of life (EOL).
2. Describe how McGill-affiliated hospitals performed on previously validated EOL quality indicators
3. Describe how physician goals of therapy, level of intervention discussions and palliative care involvement, impacted performance on the EOL quality indicators
Contact Person: Hans Knecht, MD, Chief, Division of Hematology, Tel 514-340-8222 ext. 28799.
Ìý